120 related articles for article (PubMed ID: 7512368)
1. Analysis of deletions of the long arm of chromosome 11 in hematologic malignancies with fluorescence in situ hybridization.
Kobayashi H; Espinosa R; Fernald AA; Begy C; Diaz MO; Le Beau MM; Rowley JD
Genes Chromosomes Cancer; 1993 Dec; 8(4):246-52. PubMed ID: 7512368
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases.
Kobayashi H; Montgomery KT; Bohlander SK; Adra CN; Lim BL; Kucherlapati RS; Donis-Keller H; Holt MS; Le Beau MM; Rowley JD
Blood; 1994 Nov; 84(10):3473-82. PubMed ID: 7949101
[TBL] [Abstract][Full Text] [Related]
3. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies.
Sato Y; Suto Y; Pietenpol J; Golub TR; Gilliland DG; Davis EM; Le Beau MM; Roberts JM; Vogelstein B; Rowley JD
Blood; 1995 Aug; 86(4):1525-33. PubMed ID: 7632960
[TBL] [Abstract][Full Text] [Related]
4. Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients.
Zatkova A; Ullmann R; Rouillard JM; Lamb BJ; Kuick R; Hanash SM; Schnittger S; Schoch C; Fonatsch C; Wimmer K
Genes Chromosomes Cancer; 2004 Apr; 39(4):263-76. PubMed ID: 14978788
[TBL] [Abstract][Full Text] [Related]
5. Overlapping deletion regions at 11q23 in myelodysplastic syndrome and chronic lymphocytic leukemia, characterized by a novel BAC probe set.
Siew-Gek Lee A; Rudduck-Sivaswaren C; Khun-Hong Lie D; Li-Ming Chua C; Tien SL; Morsberger L; Griffin CA
Cancer Genet Cytogenet; 2004 Sep; 153(2):151-7. PubMed ID: 15350305
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2.
Höglund M; Johansson B; Pedersen-Bjergaard J; Marynen P; Mitelman F
Blood; 1996 Jan; 87(1):324-30. PubMed ID: 8547659
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities.
Mathew S; Behm F; Dalton J; Raimondi S
Leukemia; 1999 Nov; 13(11):1713-20. PubMed ID: 10557043
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.
Johansson B; Mertens F; Mitelman F
Genes Chromosomes Cancer; 1993 Dec; 8(4):205-18. PubMed ID: 7512363
[TBL] [Abstract][Full Text] [Related]
9. Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. European 11q23 Workshop participants.
Harbott J; Mancini M; Verellen-Dumoulin C; Moorman AV; Secker-Walker LM
Leukemia; 1998 May; 12(5):823-7. PubMed ID: 9593287
[TBL] [Abstract][Full Text] [Related]
10. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents.
Andersen MK; Christiansen DH; Kirchhoff M; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2001 May; 31(1):33-41. PubMed ID: 11284033
[TBL] [Abstract][Full Text] [Related]
11. Routine fluorescence in situ hybridization with the MLL probe does not reliably detect two separate signals on one chromosome 11 in patients with trisomy 11.
Smith A; Robson L; Heaps LS; Sharma P; Dunlop L; Bhave A; Bradstock K
Cancer Genet Cytogenet; 2001 Sep; 129(2):173-6. PubMed ID: 11566351
[TBL] [Abstract][Full Text] [Related]
12. Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridization.
Kobayashi H; Espinosa R; Thirman MJ; Fernald AA; Shannon K; Diaz MO; Le Beau MM; Rowley JD
Genes Chromosomes Cancer; 1993 Aug; 7(4):204-8. PubMed ID: 7692945
[TBL] [Abstract][Full Text] [Related]
13. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
Tosi S; Harbott J; Haas OA; Douglas A; Hughes DM; Ross FM; Biondi A; Scherer SW; Kearney L
Leukemia; 1996 Apr; 10(4):644-9. PubMed ID: 8618441
[TBL] [Abstract][Full Text] [Related]
14. Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL).
Lens D; Matutes E; Catovsky D; Coignet LJ
Leukemia; 2000 Mar; 14(3):427-30. PubMed ID: 10720137
[TBL] [Abstract][Full Text] [Related]
15. Inversion of chromosome 11 inv(11)(p15q22), as a recurring chromosomal aberration associated with de novo and secondary myeloid malignancies: identification of a P1 clone spanning the 11q22 breakpoint.
Kobayashi H; Arai Y; Hosoda F; Maseki N; Hayashi Y; Eguchi H; Ohki M; Kaneko Y
Genes Chromosomes Cancer; 1997 Jul; 19(3):150-5. PubMed ID: 9218995
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements.
Andreasson P; Johansson B; Billström R; Garwicz S; Mitelman F; Höglund M
Leukemia; 1998 Mar; 12(3):390-400. PubMed ID: 9529134
[TBL] [Abstract][Full Text] [Related]
17. 11q deletions in hematological malignancies.
Monni O; Knuutila S
Leuk Lymphoma; 2001 Jan; 40(3-4):259-66. PubMed ID: 11426547
[TBL] [Abstract][Full Text] [Related]
18. Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not
Zuo W; Wang SA; DiNardo C; Yabe M; Li S; Medeiros LJ; Tang G
J Clin Pathol; 2017 Mar; 70(3):244-249. PubMed ID: 27496968
[TBL] [Abstract][Full Text] [Related]
19. A study on 289 consecutive Korean patients with acute leukaemias revealed fluorescence in situ hybridization detects the MLL translocation without cytogenetic evidence both initially and during follow-up.
Kim HJ; Cho HI; Kim EC; Ko EK; See CJ; Park SY; Lee DS
Br J Haematol; 2002 Dec; 119(4):930-9. PubMed ID: 12472570
[TBL] [Abstract][Full Text] [Related]
20. The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberration in different hematological malignancies.
Wlodarska I; Marynen P; La Starza R; Mecucci C; Van den Berghe H
Cytogenet Cell Genet; 1996; 72(2-3):229-35. PubMed ID: 8978784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
